161. Expert Rev Clin Pharmacol. 2018 Apr;11(4):325-328. doi:10.1080/17512433.2018.1439736.A new class of agents for estrogen-receptor-positive breast cancer.Ekoue DN(1)(2), Unni N(3), Raj GV(1)(2).Author information: (1)a Department of Urology , University of Texas Southwestern Medical Center ,Dallas , TX , USA.(2)b Department of Pharmacology , University of Texas Southwestern Medical Center, Dallas , TX , USA.(3)c Department of Medical Oncology , University of Texas Southwestern MedicalCenter , Dallas , TX , USA.DOI: 10.1080/17512433.2018.1439736 PMID: 29439601  [Indexed for MEDLINE]